Achieve Life Sciences, Inc. Share Price
NASDAQ: ACHVAchieve Life Sciences, Inc. Stock Performance
Achieve Life Sciences, Inc. Share Price Today
As of 19 September 2026, Achieve Life Sciences, Inc.'s share price is $7.99. The stock opened at $7.90, compared to its previous close of $7.92. During today's trading session, Achieve Life Sciences, Inc.'s share price traded between $7.88 and $8.08, with an average price of $7.98. Over the past 52 weeks, the stock has recorded a high of $8.61 and a low of $2.63. In terms of performance, Achieve Life Sciences, Inc.'s share price has risen by 171.77% over the last six months and is up 153.25% on a year-on-year basis.
Achieve Life Sciences, Inc. Share Price Chart
About Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
Achieve Life Sciences, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Sep 2026 | $7.92 | $8.00 | -2.14% |
Aug 2026 | $6.30 | $8.18 | +27.73% |
Jul 2026 | $6.60 | $6.40 | -2.14% |
Jun 2026 | $5.14 | $6.54 | +24.57% |
May 2026 | $4.28 | $5.25 | +19.86% |
Apr 2026 | $3.00 | $4.38 | +48.98% |
Mar 2026 | $4.55 | $2.94 | -35.60% |
Feb 2026 | $4.14 | $4.57 | +9.47% |
Jan 2026 | $4.83 | $4.17 | -16.27% |
Dec 2025 | $4.76 | $4.98 | +1.84% |
Nov 2025 | $5.19 | $4.89 | -4.68% |
Oct 2025 | $3.17 | $5.13 | +62.60% |